nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—hematologic cancer	0.398	0.569	CbGaD
Amifostine—ALPL—hematologic cancer	0.302	0.431	CbGaD
Amifostine—ENPP1—hematopoietic system—hematologic cancer	0.00584	0.104	CbGeAlD
Amifostine—ALPPL2—hematopoietic system—hematologic cancer	0.00563	0.1	CbGeAlD
Amifostine—ALPPL2—gonad—hematologic cancer	0.00428	0.0762	CbGeAlD
Amifostine—ALPL—blood—hematologic cancer	0.00421	0.0751	CbGeAlD
Amifostine—ENPP1—blood—hematologic cancer	0.00387	0.0689	CbGeAlD
Amifostine—ALPPL2—blood—hematologic cancer	0.00373	0.0664	CbGeAlD
Amifostine—ALPL—lung—hematologic cancer	0.00369	0.0658	CbGeAlD
Amifostine—ALPPL2—bone marrow—hematologic cancer	0.00361	0.0643	CbGeAlD
Amifostine—ALPL—testis—hematologic cancer	0.00348	0.0621	CbGeAlD
Amifostine—ENPP1—lung—hematologic cancer	0.00339	0.0604	CbGeAlD
Amifostine—ALPPL2—lung—hematologic cancer	0.00327	0.0582	CbGeAlD
Amifostine—ENPP1—testis—hematologic cancer	0.0032	0.057	CbGeAlD
Amifostine—ALPPL2—testis—hematologic cancer	0.00308	0.0549	CbGeAlD
Amifostine—ALPL—lymph node—hematologic cancer	0.00252	0.045	CbGeAlD
Amifostine—ENPP1—lymph node—hematologic cancer	0.00232	0.0413	CbGeAlD
Amifostine—ALPL—Etoposide—Teniposide—hematologic cancer	0.0023	0.591	CbGdCrCtD
Amifostine—ALPL—Endochondral Ossification—PTHLH—hematologic cancer	0.00105	0.0126	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—STAT5B—hematologic cancer	0.00102	0.0122	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—ALPL—hematologic cancer	0.00102	0.0122	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—hematologic cancer	0.000995	0.0119	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—PRKCZ—hematologic cancer	0.000949	0.0113	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—hematologic cancer	0.000925	0.011	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PTHLH—hematologic cancer	0.000896	0.0107	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—hematologic cancer	0.000881	0.0105	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—TIAM1—hematologic cancer	0.000841	0.01	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CYCS—hematologic cancer	0.000828	0.00986	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—STAT1—hematologic cancer	0.000813	0.00968	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT1—hematologic cancer	0.000793	0.00945	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTR—hematologic cancer	0.000754	0.00899	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SGK1—hematologic cancer	0.000719	0.00857	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT5A—hematologic cancer	0.000713	0.0085	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—STAT1—hematologic cancer	0.000691	0.00823	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—FOXO1—hematologic cancer	0.000653	0.00778	CbGpPWpGaD
Amifostine—ALPL—Gemcitabine—Cytarabine—hematologic cancer	0.000638	0.164	CbGdCrCtD
Amifostine—ALPL—BDNF signaling pathway—STAT5B—hematologic cancer	0.000628	0.00748	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NCAM1—hematologic cancer	0.000593	0.00706	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—EIF4EBP1—hematologic cancer	0.000557	0.00664	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—FGFR3—hematologic cancer	0.000556	0.00662	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK14—hematologic cancer	0.000537	0.0064	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NFKBIA—hematologic cancer	0.000514	0.00612	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—RAC2—hematologic cancer	0.000498	0.00594	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—FGFR3—hematologic cancer	0.000472	0.00563	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP8—hematologic cancer	0.000464	0.00552	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAP2K1—hematologic cancer	0.00044	0.00525	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—EIF4EBP1—hematologic cancer	0.000436	0.00519	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—FGF2—hematologic cancer	0.000429	0.00512	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT1—hematologic cancer	0.000425	0.00506	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—hematologic cancer	0.000404	0.00481	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—JAK2—hematologic cancer	0.000402	0.00479	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PRKCZ—hematologic cancer	0.000397	0.00474	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—GRB2—hematologic cancer	0.000397	0.00474	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT5A—hematologic cancer	0.000382	0.00455	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—FGF2—hematologic cancer	0.000365	0.00435	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—CBL—hematologic cancer	0.000361	0.0043	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PTPN1—hematologic cancer	0.000351	0.00418	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—hematologic cancer	0.000351	0.00418	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—JUN—hematologic cancer	0.000341	0.00406	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK8—hematologic cancer	0.000322	0.00384	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—GRB2—hematologic cancer	0.000311	0.0037	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—SRC—hematologic cancer	0.000306	0.00364	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—hematologic cancer	0.000305	0.00364	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—TSC2—hematologic cancer	0.000302	0.0036	CbGpPWpGaD
Amifostine—ENPP1—Disease—LYZ—hematologic cancer	0.000296	0.00353	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—hematologic cancer	0.000295	0.00351	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK14—hematologic cancer	0.000288	0.00343	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK3—hematologic cancer	0.000282	0.00336	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—hematologic cancer	0.00028	0.00334	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—BAD—hematologic cancer	0.000275	0.00328	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NFKBIA—hematologic cancer	0.000275	0.00328	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—FOXO1—hematologic cancer	0.000274	0.00326	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—PTPN11—hematologic cancer	0.000262	0.00312	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—hematologic cancer	0.000259	0.00309	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—FOS—hematologic cancer	0.000254	0.00303	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CREB1—hematologic cancer	0.000254	0.00302	CbGpPWpGaD
Amifostine—ENPP1—Disease—PPEF1—hematologic cancer	0.000241	0.00287	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—hematologic cancer	0.000238	0.00284	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—TSC2—hematologic cancer	0.000236	0.00281	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAP2K1—hematologic cancer	0.000236	0.00281	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAPK14—hematologic cancer	0.000225	0.00268	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—PIK3R1—hematologic cancer	0.000221	0.00264	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—FTCD—hematologic cancer	0.000221	0.00263	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GMPS—hematologic cancer	0.000221	0.00263	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PHYH—hematologic cancer	0.000221	0.00263	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—JAK2—hematologic cancer	0.000215	0.00256	CbGpPWpGaD
Amifostine—ENPP1—Disease—B3GAT1—hematologic cancer	0.000211	0.00251	CbGpPWpGaD
Amifostine—ENPP1—Disease—CHMP5—hematologic cancer	0.000211	0.00251	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—hematologic cancer	0.000208	0.00248	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PTPN11—hematologic cancer	0.000205	0.00244	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MTOR—hematologic cancer	0.000204	0.00243	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SMPD3—hematologic cancer	0.000202	0.00241	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—FOS—hematologic cancer	0.000199	0.00237	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—AKT1—hematologic cancer	0.000195	0.00232	CbGpPWpGaD
Amifostine—ENPP1—Disease—HDAC11—hematologic cancer	0.000191	0.00227	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—hematologic cancer	0.00019	0.00226	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CASP3—hematologic cancer	0.000188	0.00224	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAP2K1—hematologic cancer	0.000184	0.0022	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—hematologic cancer	0.000183	0.00218	CbGpPWpGaD
Amifostine—ENPP1—Disease—BCR—hematologic cancer	0.000183	0.00218	CbGpPWpGaD
Amifostine—ENPP1—Disease—LIG4—hematologic cancer	0.000183	0.00218	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—JUN—hematologic cancer	0.000183	0.00218	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—B3GAT1—hematologic cancer	0.000177	0.0021	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ASNS—hematologic cancer	0.000177	0.0021	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—DCK—hematologic cancer	0.000177	0.0021	CbGpPWpGaD
Amifostine—ENPP1—Disease—PC—hematologic cancer	0.000176	0.0021	CbGpPWpGaD
Amifostine—ENPP1—Disease—PSIP1—hematologic cancer	0.000176	0.0021	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3R1—hematologic cancer	0.000173	0.00206	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK8—hematologic cancer	0.000173	0.00206	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC35B2—hematologic cancer	0.00017	0.00203	CbGpPWpGaD
Amifostine—ENPP1—Disease—HDAC10—hematologic cancer	0.00017	0.00203	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HDC—hematologic cancer	0.000167	0.00199	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—AKT1—hematologic cancer	0.000166	0.00197	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—SRC—hematologic cancer	0.000164	0.00195	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—hematologic cancer	0.00016	0.0019	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MTOR—hematologic cancer	0.00016	0.0019	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT3—hematologic cancer	0.000158	0.00188	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CDA—hematologic cancer	0.000153	0.00182	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAPK3—hematologic cancer	0.000151	0.0018	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PC—hematologic cancer	0.000147	0.00176	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—JUN—hematologic cancer	0.000143	0.0017	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GBA—hematologic cancer	0.000142	0.0017	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC35B2—hematologic cancer	0.000142	0.0017	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PTEN—hematologic cancer	0.000138	0.00164	CbGpPWpGaD
Amifostine—ENPP1—Disease—AGRN—hematologic cancer	0.000136	0.00162	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPLP1—hematologic cancer	0.000136	0.00162	CbGpPWpGaD
Amifostine—ENPP1—Disease—SNCA—hematologic cancer	0.000136	0.00162	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAPK8—hematologic cancer	0.000135	0.00161	CbGpPWpGaD
Amifostine—ENPP1—Disease—LEF1—hematologic cancer	0.000131	0.00156	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTAP—hematologic cancer	0.00013	0.00155	CbGpPWpGaD
Amifostine—ENPP1—Disease—HMMR—hematologic cancer	0.000129	0.00153	CbGpPWpGaD
Amifostine—ENPP1—Betamethasone—Dexamethasone—hematologic cancer	0.000125	0.0321	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Betamethasone—hematologic cancer	0.000125	0.0321	CbGdCrCtD
Amifostine—ENPP1—Betamethasone—Triamcinolone—hematologic cancer	0.000122	0.0314	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Triamcinolone—hematologic cancer	0.000122	0.0314	CbGdCrCtD
Amifostine—ENPP1—Disease—ELL—hematologic cancer	0.000121	0.00144	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAPK3—hematologic cancer	0.000118	0.0014	CbGpPWpGaD
Amifostine—ENPP1—Disease—ACP5—hematologic cancer	0.000118	0.0014	CbGpPWpGaD
Amifostine—ENPP1—Disease—NCOR2—hematologic cancer	0.000116	0.00139	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—FHL2—hematologic cancer	0.000116	0.00138	CbGpPWpGaD
Amifostine—ENPP1—Betamethasone—Prednisone—hematologic cancer	0.000116	0.0298	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Prednisone—hematologic cancer	0.000116	0.0298	CbGdCrCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—hematologic cancer	0.000115	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AGRN—hematologic cancer	0.000114	0.00136	CbGpPWpGaD
Amifostine—ENPP1—Betamethasone—Prednisolone—hematologic cancer	0.000113	0.0291	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Prednisolone—hematologic cancer	0.000113	0.0291	CbGdCrCtD
Amifostine—ENPP1—Disease—IDH1—hematologic cancer	0.000111	0.00132	CbGpPWpGaD
Amifostine—ENPP1—Disease—GSTO1—hematologic cancer	0.00011	0.00131	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HMMR—hematologic cancer	0.000108	0.00129	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—IDH2—hematologic cancer	0.000108	0.00129	CbGpPWpGaD
Amifostine—ENPP1—Disease—AGO2—hematologic cancer	0.000107	0.00128	CbGpPWpGaD
Amifostine—ENPP1—Disease—HDAC9—hematologic cancer	0.000106	0.00126	CbGpPWpGaD
Amifostine—ENPP1—Disease—H3F3B—hematologic cancer	0.000105	0.00125	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—AKT1—hematologic cancer	0.000102	0.00121	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ARNTL—hematologic cancer	0.000101	0.00121	CbGpPWpGaD
Amifostine—ENPP1—Disease—NPM1—hematologic cancer	0.000101	0.0012	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CA9—hematologic cancer	9.87e-05	0.00118	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ACP5—hematologic cancer	9.87e-05	0.00118	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NCOR2—hematologic cancer	9.74e-05	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—hematologic cancer	9.74e-05	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Disease—FGF19—hematologic cancer	9.68e-05	0.00115	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPS14—hematologic cancer	9.6e-05	0.00114	CbGpPWpGaD
Amifostine—ENPP1—Disease—DKK1—hematologic cancer	9.53e-05	0.00114	CbGpPWpGaD
Amifostine—ENPP1—Disease—NUP98—hematologic cancer	9.45e-05	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT5B—hematologic cancer	9.45e-05	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—IDH1—hematologic cancer	9.28e-05	0.00111	CbGpPWpGaD
Amifostine—ENPP1—Disease—CST3—hematologic cancer	9.24e-05	0.0011	CbGpPWpGaD
Amifostine—ENPP1—Disease—ADCY7—hematologic cancer	9.18e-05	0.00109	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCC3—hematologic cancer	9.17e-05	0.00109	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—TXN—hematologic cancer	9.17e-05	0.00109	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTO1—hematologic cancer	9.17e-05	0.00109	CbGpPWpGaD
Amifostine—ENPP1—Disease—NUP214—hematologic cancer	9.11e-05	0.00109	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—HRAS—hematologic cancer	9.01e-05	0.00107	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SPHK1—hematologic cancer	8.98e-05	0.00107	CbGpPWpGaD
Amifostine—ENPP1—Disease—XIAP—hematologic cancer	8.93e-05	0.00106	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTR—hematologic cancer	8.93e-05	0.00106	CbGpPWpGaD
Amifostine—ENPP1—Disease—ENO2—hematologic cancer	8.76e-05	0.00104	CbGpPWpGaD
Amifostine—ENPP1—Disease—SMARCA4—hematologic cancer	8.7e-05	0.00104	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—UGT1A1—hematologic cancer	8.62e-05	0.00103	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CRABP1—hematologic cancer	8.39e-05	0.001	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC22A1—hematologic cancer	8.39e-05	0.001	CbGpPWpGaD
Amifostine—ENPP1—Disease—SDC1—hematologic cancer	8.3e-05	0.000989	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALOX5—hematologic cancer	8.18e-05	0.000974	CbGpPWpGaD
Amifostine—ENPP1—Disease—LCK—hematologic cancer	8.04e-05	0.000958	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—AKT1—hematologic cancer	7.95e-05	0.000948	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NUP98—hematologic cancer	7.92e-05	0.000943	CbGpPWpGaD
Amifostine—ENPP1—Disease—H3F3A—hematologic cancer	7.88e-05	0.000939	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ADCY7—hematologic cancer	7.69e-05	0.000916	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NCOA3—hematologic cancer	7.69e-05	0.000916	CbGpPWpGaD
Amifostine—ENPP1—Disease—PRKCZ—hematologic cancer	7.66e-05	0.000913	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NUP214—hematologic cancer	7.63e-05	0.000909	CbGpPWpGaD
Amifostine—ENPP1—Disease—CALR—hematologic cancer	7.53e-05	0.000897	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCG2—hematologic cancer	7.48e-05	0.000891	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTR—hematologic cancer	7.48e-05	0.000891	CbGpPWpGaD
Amifostine—ENPP1—Disease—PARP1—hematologic cancer	7.4e-05	0.000882	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ENO2—hematologic cancer	7.33e-05	0.000874	CbGpPWpGaD
Amifostine—ENPP1—Disease—FBXW7—hematologic cancer	7.28e-05	0.000867	CbGpPWpGaD
Amifostine—ENPP1—Disease—HDAC2—hematologic cancer	7.14e-05	0.00085	CbGpPWpGaD
Amifostine—ENPP1—Disease—CXCR4—hematologic cancer	7.14e-05	0.00085	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTT1—hematologic cancer	7.11e-05	0.000847	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD44—hematologic cancer	7.06e-05	0.000841	CbGpPWpGaD
Amifostine—ENPP1—Disease—CBL—hematologic cancer	6.96e-05	0.000829	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SDC1—hematologic cancer	6.95e-05	0.000828	CbGpPWpGaD
Amifostine—ENPP1—Disease—HSP90AA1—hematologic cancer	6.64e-05	0.000791	CbGpPWpGaD
Amifostine—Rash—Bortezomib—hematologic cancer	6.41e-05	0.00041	CcSEcCtD
Amifostine—Dermatitis—Bortezomib—hematologic cancer	6.41e-05	0.000409	CcSEcCtD
Amifostine—ENPP1—Disease—STAT1—hematologic cancer	6.4e-05	0.000762	CbGpPWpGaD
Amifostine—Flushing—Prednisone—hematologic cancer	6.38e-05	0.000408	CcSEcCtD
Amifostine—Ill-defined disorder—Dexamethasone—hematologic cancer	6.37e-05	0.000407	CcSEcCtD
Amifostine—Ill-defined disorder—Betamethasone—hematologic cancer	6.37e-05	0.000407	CcSEcCtD
Amifostine—Discomfort—Triamcinolone—hematologic cancer	6.37e-05	0.000407	CcSEcCtD
Amifostine—Hypotension—Etoposide—hematologic cancer	6.36e-05	0.000407	CcSEcCtD
Amifostine—Rash—Bleomycin—hematologic cancer	6.36e-05	0.000407	CcSEcCtD
Amifostine—Dermatitis—Bleomycin—hematologic cancer	6.36e-05	0.000406	CcSEcCtD
Amifostine—Hypersensitivity—Ifosfamide—hematologic cancer	6.35e-05	0.000406	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	6.34e-05	0.000405	CcSEcCtD
Amifostine—Vomiting—Vinorelbine—hematologic cancer	6.31e-05	0.000404	CcSEcCtD
Amifostine—Body temperature increased—Gemcitabine—hematologic cancer	6.31e-05	0.000403	CcSEcCtD
Amifostine—Renal failure—Methotrexate—hematologic cancer	6.29e-05	0.000402	CcSEcCtD
Amifostine—Dizziness—Thiotepa—hematologic cancer	6.27e-05	0.000401	CcSEcCtD
Amifostine—Rash—Vinorelbine—hematologic cancer	6.26e-05	0.0004	CcSEcCtD
Amifostine—Dermatitis—Vinorelbine—hematologic cancer	6.25e-05	0.0004	CcSEcCtD
Amifostine—Hypersensitivity—Vincristine—hematologic cancer	6.19e-05	0.000396	CcSEcCtD
Amifostine—Malaise—Betamethasone—hematologic cancer	6.19e-05	0.000396	CcSEcCtD
Amifostine—Malaise—Dexamethasone—hematologic cancer	6.19e-05	0.000396	CcSEcCtD
Amifostine—Anaphylactic shock—Triamcinolone—hematologic cancer	6.18e-05	0.000395	CcSEcCtD
Amifostine—Pruritus—Alitretinoin—hematologic cancer	6.17e-05	0.000395	CcSEcCtD
Amifostine—Syncope—Dexamethasone—hematologic cancer	6.16e-05	0.000394	CcSEcCtD
Amifostine—Syncope—Betamethasone—hematologic cancer	6.16e-05	0.000394	CcSEcCtD
Amifostine—Arrhythmia—Prednisone—hematologic cancer	6.14e-05	0.000392	CcSEcCtD
Amifostine—Feeling abnormal—Cisplatin—hematologic cancer	6.13e-05	0.000392	CcSEcCtD
Amifostine—Pruritus—Ifosfamide—hematologic cancer	6.1e-05	0.00039	CcSEcCtD
Amifostine—Shock—Triamcinolone—hematologic cancer	6.08e-05	0.000389	CcSEcCtD
Amifostine—Dyspnoea—Etoposide—hematologic cancer	6.07e-05	0.000388	CcSEcCtD
Amifostine—Dizziness—Thalidomide—hematologic cancer	6.06e-05	0.000388	CcSEcCtD
Amifostine—Somnolence—Etoposide—hematologic cancer	6.05e-05	0.000387	CcSEcCtD
Amifostine—Nausea—Bortezomib—hematologic cancer	6.04e-05	0.000386	CcSEcCtD
Amifostine—Loss of consciousness—Dexamethasone—hematologic cancer	6.04e-05	0.000386	CcSEcCtD
Amifostine—Loss of consciousness—Betamethasone—hematologic cancer	6.04e-05	0.000386	CcSEcCtD
Amifostine—Hypersensitivity—Irinotecan—hematologic cancer	6.03e-05	0.000386	CcSEcCtD
Amifostine—Hypersensitivity—Mitoxantrone—hematologic cancer	6.03e-05	0.000386	CcSEcCtD
Amifostine—Tachycardia—Triamcinolone—hematologic cancer	6.03e-05	0.000385	CcSEcCtD
Amifostine—Vomiting—Thiotepa—hematologic cancer	6.03e-05	0.000385	CcSEcCtD
Amifostine—Nausea—Bleomycin—hematologic cancer	5.99e-05	0.000383	CcSEcCtD
Amifostine—ENPP1—Disease—GRB2—hematologic cancer	5.99e-05	0.000713	CbGpPWpGaD
Amifostine—Rash—Thiotepa—hematologic cancer	5.98e-05	0.000382	CcSEcCtD
Amifostine—Dermatitis—Thiotepa—hematologic cancer	5.97e-05	0.000382	CcSEcCtD
Amifostine—ENPP1—Disease—PDGFA—hematologic cancer	5.97e-05	0.000712	CbGpPWpGaD
Amifostine—Convulsion—Betamethasone—hematologic cancer	5.95e-05	0.00038	CcSEcCtD
Amifostine—Convulsion—Dexamethasone—hematologic cancer	5.95e-05	0.00038	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	5.93e-05	0.000379	CcSEcCtD
Amifostine—Hypertension—Betamethasone—hematologic cancer	5.93e-05	0.000379	CcSEcCtD
Amifostine—Hypertension—Dexamethasone—hematologic cancer	5.93e-05	0.000379	CcSEcCtD
Amifostine—ENPP1—Metabolism—CD44—hematologic cancer	5.91e-05	0.000704	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NQO1—hematologic cancer	5.91e-05	0.000704	CbGpPWpGaD
Amifostine—Nausea—Vinorelbine—hematologic cancer	5.9e-05	0.000377	CcSEcCtD
Amifostine—ENPP1—Disease—KITLG—hematologic cancer	5.89e-05	0.000701	CbGpPWpGaD
Amifostine—Renal failure—Epirubicin—hematologic cancer	5.88e-05	0.000376	CcSEcCtD
Amifostine—Body temperature increased—Cisplatin—hematologic cancer	5.88e-05	0.000376	CcSEcCtD
Amifostine—Vomiting—Thalidomide—hematologic cancer	5.83e-05	0.000373	CcSEcCtD
Amifostine—Dizziness—Carmustine—hematologic cancer	5.82e-05	0.000372	CcSEcCtD
Amifostine—Rash—Thalidomide—hematologic cancer	5.78e-05	0.00037	CcSEcCtD
Amifostine—Discomfort—Betamethasone—hematologic cancer	5.78e-05	0.000369	CcSEcCtD
Amifostine—Discomfort—Dexamethasone—hematologic cancer	5.78e-05	0.000369	CcSEcCtD
Amifostine—Dermatitis—Thalidomide—hematologic cancer	5.78e-05	0.000369	CcSEcCtD
Amifostine—Dizziness—Alitretinoin—hematologic cancer	5.77e-05	0.000369	CcSEcCtD
Amifostine—ENPP1—Disease—STAT5A—hematologic cancer	5.75e-05	0.000686	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN2B—hematologic cancer	5.7e-05	0.00068	CbGpPWpGaD
Amifostine—Dizziness—Ifosfamide—hematologic cancer	5.7e-05	0.000365	CcSEcCtD
Amifostine—Pruritus—Gemcitabine—hematologic cancer	5.64e-05	0.000361	CcSEcCtD
Amifostine—Nausea—Thiotepa—hematologic cancer	5.63e-05	0.00036	CcSEcCtD
Amifostine—Feeling abnormal—Etoposide—hematologic cancer	5.61e-05	0.000359	CcSEcCtD
Amifostine—Anaphylactic shock—Dexamethasone—hematologic cancer	5.61e-05	0.000358	CcSEcCtD
Amifostine—Anaphylactic shock—Betamethasone—hematologic cancer	5.61e-05	0.000358	CcSEcCtD
Amifostine—Vomiting—Carmustine—hematologic cancer	5.6e-05	0.000358	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYCS—hematologic cancer	5.59e-05	0.000666	CbGpPWpGaD
Amifostine—Dizziness—Vincristine—hematologic cancer	5.56e-05	0.000355	CcSEcCtD
Amifostine—ENPP1—Metabolism—HSP90AA1—hematologic cancer	5.56e-05	0.000662	CbGpPWpGaD
Amifostine—Rash—Carmustine—hematologic cancer	5.55e-05	0.000355	CcSEcCtD
Amifostine—Ill-defined disorder—Prednisone—hematologic cancer	5.55e-05	0.000355	CcSEcCtD
Amifostine—Dermatitis—Carmustine—hematologic cancer	5.55e-05	0.000355	CcSEcCtD
Amifostine—Vomiting—Alitretinoin—hematologic cancer	5.55e-05	0.000355	CcSEcCtD
Amifostine—Feeling abnormal—Prednisolone—hematologic cancer	5.54e-05	0.000354	CcSEcCtD
Amifostine—ENPP1—Disease—CD86—hematologic cancer	5.52e-05	0.000657	CbGpPWpGaD
Amifostine—Shock—Dexamethasone—hematologic cancer	5.51e-05	0.000353	CcSEcCtD
Amifostine—Shock—Betamethasone—hematologic cancer	5.51e-05	0.000353	CcSEcCtD
Amifostine—Dyspnoea—Triamcinolone—hematologic cancer	5.51e-05	0.000352	CcSEcCtD
Amifostine—Rash—Alitretinoin—hematologic cancer	5.5e-05	0.000352	CcSEcCtD
Amifostine—Dermatitis—Alitretinoin—hematologic cancer	5.5e-05	0.000351	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.49e-05	0.000351	CcSEcCtD
Amifostine—Vomiting—Ifosfamide—hematologic cancer	5.48e-05	0.00035	CcSEcCtD
Amifostine—Hypersensitivity—Cisplatin—hematologic cancer	5.48e-05	0.00035	CcSEcCtD
Amifostine—Tachycardia—Dexamethasone—hematologic cancer	5.47e-05	0.00035	CcSEcCtD
Amifostine—Tachycardia—Betamethasone—hematologic cancer	5.47e-05	0.00035	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—hematologic cancer	5.47e-05	0.00035	CcSEcCtD
Amifostine—Nausea—Thalidomide—hematologic cancer	5.45e-05	0.000348	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—hematologic cancer	5.44e-05	0.000348	CcSEcCtD
Amifostine—ENPP1—Disease—HES1—hematologic cancer	5.44e-05	0.000648	CbGpPWpGaD
Amifostine—Rash—Ifosfamide—hematologic cancer	5.44e-05	0.000348	CcSEcCtD
Amifostine—Dermatitis—Ifosfamide—hematologic cancer	5.43e-05	0.000347	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—hematologic cancer	5.43e-05	0.000347	CcSEcCtD
Amifostine—Dizziness—Irinotecan—hematologic cancer	5.41e-05	0.000346	CcSEcCtD
Amifostine—Urticaria—Etoposide—hematologic cancer	5.41e-05	0.000346	CcSEcCtD
Amifostine—ENPP1—Disease—NCOR1—hematologic cancer	5.41e-05	0.000645	CbGpPWpGaD
Amifostine—Malaise—Prednisone—hematologic cancer	5.39e-05	0.000345	CcSEcCtD
Amifostine—Body temperature increased—Etoposide—hematologic cancer	5.38e-05	0.000344	CcSEcCtD
Amifostine—Syncope—Prednisone—hematologic cancer	5.36e-05	0.000343	CcSEcCtD
Amifostine—ENPP1—Disease—FGF1—hematologic cancer	5.35e-05	0.000637	CbGpPWpGaD
Amifostine—Vomiting—Vincristine—hematologic cancer	5.35e-05	0.000342	CcSEcCtD
Amifostine—Urticaria—Prednisolone—hematologic cancer	5.34e-05	0.000341	CcSEcCtD
Amifostine—Rash—Vincristine—hematologic cancer	5.3e-05	0.000339	CcSEcCtD
Amifostine—Dermatitis—Vincristine—hematologic cancer	5.3e-05	0.000339	CcSEcCtD
Amifostine—ENPP1—Disease—FOXO1—hematologic cancer	5.27e-05	0.000628	CbGpPWpGaD
Amifostine—ENPP1—Disease—PDGFRB—hematologic cancer	5.26e-05	0.000627	CbGpPWpGaD
Amifostine—Loss of consciousness—Prednisone—hematologic cancer	5.26e-05	0.000336	CcSEcCtD
Amifostine—Hypotension—Betamethasone—hematologic cancer	5.24e-05	0.000335	CcSEcCtD
Amifostine—Hypotension—Dexamethasone—hematologic cancer	5.24e-05	0.000335	CcSEcCtD
Amifostine—Nausea—Carmustine—hematologic cancer	5.23e-05	0.000334	CcSEcCtD
Amifostine—Vomiting—Irinotecan—hematologic cancer	5.21e-05	0.000333	CcSEcCtD
Amifostine—Vomiting—Mitoxantrone—hematologic cancer	5.21e-05	0.000333	CcSEcCtD
Amifostine—Nausea—Alitretinoin—hematologic cancer	5.18e-05	0.000331	CcSEcCtD
Amifostine—Convulsion—Prednisone—hematologic cancer	5.18e-05	0.000331	CcSEcCtD
Amifostine—ENPP1—Disease—PDGFRA—hematologic cancer	5.18e-05	0.000617	CbGpPWpGaD
Amifostine—Hypertension—Prednisone—hematologic cancer	5.16e-05	0.00033	CcSEcCtD
Amifostine—Rash—Mitoxantrone—hematologic cancer	5.16e-05	0.00033	CcSEcCtD
Amifostine—Rash—Irinotecan—hematologic cancer	5.16e-05	0.00033	CcSEcCtD
Amifostine—ENPP1—Disease—PRKCG—hematologic cancer	5.16e-05	0.000615	CbGpPWpGaD
Amifostine—ENPP1—Disease—JAK1—hematologic cancer	5.16e-05	0.000615	CbGpPWpGaD
Amifostine—Dermatitis—Irinotecan—hematologic cancer	5.16e-05	0.00033	CcSEcCtD
Amifostine—Dermatitis—Mitoxantrone—hematologic cancer	5.16e-05	0.00033	CcSEcCtD
Amifostine—Chills—Methotrexate—hematologic cancer	5.15e-05	0.000329	CcSEcCtD
Amifostine—Nausea—Ifosfamide—hematologic cancer	5.12e-05	0.000327	CcSEcCtD
Amifostine—Feeling abnormal—Triamcinolone—hematologic cancer	5.09e-05	0.000325	CcSEcCtD
Amifostine—Erythema multiforme—Epirubicin—hematologic cancer	5.08e-05	0.000325	CcSEcCtD
Amifostine—Vomiting—Gemcitabine—hematologic cancer	5.07e-05	0.000324	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—hematologic cancer	5.06e-05	0.000324	CcSEcCtD
Amifostine—Discomfort—Prednisone—hematologic cancer	5.03e-05	0.000322	CcSEcCtD
Amifostine—Rash—Gemcitabine—hematologic cancer	5.03e-05	0.000321	CcSEcCtD
Amifostine—Dermatitis—Gemcitabine—hematologic cancer	5.02e-05	0.000321	CcSEcCtD
Amifostine—Hypersensitivity—Etoposide—hematologic cancer	5.02e-05	0.000321	CcSEcCtD
Amifostine—Nausea—Vincristine—hematologic cancer	4.99e-05	0.000319	CcSEcCtD
Amifostine—Flushing—Epirubicin—hematologic cancer	4.99e-05	0.000319	CcSEcCtD
Amifostine—Hypersensitivity—Prednisolone—hematologic cancer	4.95e-05	0.000316	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTP1—hematologic cancer	4.93e-05	0.000587	CbGpPWpGaD
Amifostine—Urticaria—Triamcinolone—hematologic cancer	4.91e-05	0.000314	CcSEcCtD
Amifostine—Body temperature increased—Triamcinolone—hematologic cancer	4.88e-05	0.000312	CcSEcCtD
Amifostine—Anaphylactic shock—Prednisone—hematologic cancer	4.88e-05	0.000312	CcSEcCtD
Amifostine—Nausea—Irinotecan—hematologic cancer	4.86e-05	0.000311	CcSEcCtD
Amifostine—Nausea—Mitoxantrone—hematologic cancer	4.86e-05	0.000311	CcSEcCtD
Amifostine—Chills—Epirubicin—hematologic cancer	4.82e-05	0.000308	CcSEcCtD
Amifostine—Pruritus—Etoposide—hematologic cancer	4.82e-05	0.000308	CcSEcCtD
Amifostine—Shock—Prednisone—hematologic cancer	4.8e-05	0.000307	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—hematologic cancer	4.8e-05	0.000307	CcSEcCtD
Amifostine—ENPP1—Disease—MTHFR—hematologic cancer	4.78e-05	0.00057	CbGpPWpGaD
Amifostine—ENPP1—Disease—TERT—hematologic cancer	4.77e-05	0.000568	CbGpPWpGaD
Amifostine—ENPP1—Disease—HLA-A—hematologic cancer	4.77e-05	0.000568	CbGpPWpGaD
Amifostine—Tachycardia—Prednisone—hematologic cancer	4.76e-05	0.000305	CcSEcCtD
Amifostine—Nausea—Gemcitabine—hematologic cancer	4.74e-05	0.000303	CcSEcCtD
Amifostine—Vomiting—Cisplatin—hematologic cancer	4.73e-05	0.000302	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—hematologic cancer	4.7e-05	0.000301	CcSEcCtD
Amifostine—Rash—Cisplatin—hematologic cancer	4.69e-05	0.0003	CcSEcCtD
Amifostine—Dermatitis—Cisplatin—hematologic cancer	4.68e-05	0.000299	CcSEcCtD
Amifostine—ENPP1—Metabolism—ABCB1—hematologic cancer	4.67e-05	0.000556	CbGpPWpGaD
Amifostine—ENPP1—Disease—PDGFB—hematologic cancer	4.65e-05	0.000554	CbGpPWpGaD
Amifostine—Ill-defined disorder—Methotrexate—hematologic cancer	4.64e-05	0.000296	CcSEcCtD
Amifostine—Feeling abnormal—Betamethasone—hematologic cancer	4.62e-05	0.000295	CcSEcCtD
Amifostine—Feeling abnormal—Dexamethasone—hematologic cancer	4.62e-05	0.000295	CcSEcCtD
Amifostine—Flushing—Doxorubicin—hematologic cancer	4.61e-05	0.000295	CcSEcCtD
Amifostine—Hypersensitivity—Triamcinolone—hematologic cancer	4.55e-05	0.000291	CcSEcCtD
Amifostine—ENPP1—Disease—TSC2—hematologic cancer	4.55e-05	0.000542	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTM1—hematologic cancer	4.53e-05	0.00054	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NCOR1—hematologic cancer	4.53e-05	0.00054	CbGpPWpGaD
Amifostine—Malaise—Methotrexate—hematologic cancer	4.51e-05	0.000288	CcSEcCtD
Amifostine—Dizziness—Etoposide—hematologic cancer	4.5e-05	0.000288	CcSEcCtD
Amifostine—Chills—Doxorubicin—hematologic cancer	4.46e-05	0.000285	CcSEcCtD
Amifostine—Urticaria—Dexamethasone—hematologic cancer	4.45e-05	0.000285	CcSEcCtD
Amifostine—Urticaria—Betamethasone—hematologic cancer	4.45e-05	0.000285	CcSEcCtD
Amifostine—Dizziness—Prednisolone—hematologic cancer	4.44e-05	0.000284	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—hematologic cancer	4.44e-05	0.000284	CcSEcCtD
Amifostine—Body temperature increased—Dexamethasone—hematologic cancer	4.43e-05	0.000283	CcSEcCtD
Amifostine—Body temperature increased—Betamethasone—hematologic cancer	4.43e-05	0.000283	CcSEcCtD
Amifostine—Nausea—Cisplatin—hematologic cancer	4.42e-05	0.000282	CcSEcCtD
Amifostine—ENPP1—Disease—FGFR3—hematologic cancer	4.37e-05	0.000521	CbGpPWpGaD
Amifostine—Pruritus—Triamcinolone—hematologic cancer	4.37e-05	0.000279	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—hematologic cancer	4.34e-05	0.000277	CcSEcCtD
Amifostine—Convulsion—Methotrexate—hematologic cancer	4.33e-05	0.000277	CcSEcCtD
Amifostine—Vomiting—Etoposide—hematologic cancer	4.33e-05	0.000277	CcSEcCtD
Amifostine—Rash—Etoposide—hematologic cancer	4.29e-05	0.000275	CcSEcCtD
Amifostine—Dermatitis—Etoposide—hematologic cancer	4.29e-05	0.000274	CcSEcCtD
Amifostine—Chest pain—Methotrexate—hematologic cancer	4.26e-05	0.000272	CcSEcCtD
Amifostine—Rash—Prednisolone—hematologic cancer	4.24e-05	0.000271	CcSEcCtD
Amifostine—Dermatitis—Prednisolone—hematologic cancer	4.23e-05	0.00027	CcSEcCtD
Amifostine—Malaise—Epirubicin—hematologic cancer	4.22e-05	0.00027	CcSEcCtD
Amifostine—Discomfort—Methotrexate—hematologic cancer	4.2e-05	0.000269	CcSEcCtD
Amifostine—Syncope—Epirubicin—hematologic cancer	4.2e-05	0.000268	CcSEcCtD
Amifostine—ENPP1—Disease—BAD—hematologic cancer	4.15e-05	0.000494	CbGpPWpGaD
Amifostine—Loss of consciousness—Epirubicin—hematologic cancer	4.11e-05	0.000263	CcSEcCtD
Amifostine—ENPP1—Disease—NOTCH1—hematologic cancer	4.11e-05	0.000489	CbGpPWpGaD
Amifostine—Dizziness—Triamcinolone—hematologic cancer	4.09e-05	0.000261	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—hematologic cancer	4.08e-05	0.000261	CcSEcCtD
Amifostine—Convulsion—Epirubicin—hematologic cancer	4.05e-05	0.000259	CcSEcCtD
Amifostine—Nausea—Etoposide—hematologic cancer	4.05e-05	0.000259	CcSEcCtD
Amifostine—Hypertension—Epirubicin—hematologic cancer	4.04e-05	0.000258	CcSEcCtD
Amifostine—ENPP1—Disease—CD80—hematologic cancer	4.02e-05	0.000479	CbGpPWpGaD
Amifostine—Feeling abnormal—Prednisone—hematologic cancer	4.02e-05	0.000257	CcSEcCtD
Amifostine—ENPP1—Disease—KIT—hematologic cancer	4.02e-05	0.000479	CbGpPWpGaD
Amifostine—Ill-defined disorder—Doxorubicin—hematologic cancer	4.02e-05	0.000257	CcSEcCtD
Amifostine—ENPP1—Metabolism—MTHFR—hematologic cancer	4e-05	0.000477	CbGpPWpGaD
Amifostine—Nausea—Prednisolone—hematologic cancer	3.99e-05	0.000255	CcSEcCtD
Amifostine—Chest pain—Epirubicin—hematologic cancer	3.98e-05	0.000255	CcSEcCtD
Amifostine—Pruritus—Dexamethasone—hematologic cancer	3.97e-05	0.000253	CcSEcCtD
Amifostine—Pruritus—Betamethasone—hematologic cancer	3.97e-05	0.000253	CcSEcCtD
Amifostine—ENPP1—Disease—PTPN11—hematologic cancer	3.95e-05	0.00047	CbGpPWpGaD
Amifostine—Discomfort—Epirubicin—hematologic cancer	3.93e-05	0.000252	CcSEcCtD
Amifostine—Vomiting—Triamcinolone—hematologic cancer	3.93e-05	0.000251	CcSEcCtD
Amifostine—Malaise—Doxorubicin—hematologic cancer	3.9e-05	0.00025	CcSEcCtD
Amifostine—Rash—Triamcinolone—hematologic cancer	3.9e-05	0.000249	CcSEcCtD
Amifostine—Dermatitis—Triamcinolone—hematologic cancer	3.89e-05	0.000249	CcSEcCtD
Amifostine—Syncope—Doxorubicin—hematologic cancer	3.88e-05	0.000248	CcSEcCtD
Amifostine—Urticaria—Prednisone—hematologic cancer	3.88e-05	0.000248	CcSEcCtD
Amifostine—Body temperature increased—Prednisone—hematologic cancer	3.86e-05	0.000247	CcSEcCtD
Amifostine—ENPP1—Disease—CREB1—hematologic cancer	3.82e-05	0.000456	CbGpPWpGaD
Amifostine—Anaphylactic shock—Epirubicin—hematologic cancer	3.82e-05	0.000244	CcSEcCtD
Amifostine—Hypotension—Methotrexate—hematologic cancer	3.81e-05	0.000244	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—hematologic cancer	3.8e-05	0.000243	CcSEcCtD
Amifostine—ENPP1—Disease—BRAF—hematologic cancer	3.78e-05	0.00045	CbGpPWpGaD
Amifostine—Shock—Epirubicin—hematologic cancer	3.76e-05	0.00024	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—hematologic cancer	3.75e-05	0.00024	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—hematologic cancer	3.74e-05	0.000239	CcSEcCtD
Amifostine—ENPP1—Disease—IL6R—hematologic cancer	3.73e-05	0.000444	CbGpPWpGaD
Amifostine—Tachycardia—Epirubicin—hematologic cancer	3.73e-05	0.000238	CcSEcCtD
Amifostine—ENPP1—Disease—CREBBP—hematologic cancer	3.72e-05	0.000444	CbGpPWpGaD
Amifostine—Dizziness—Dexamethasone—hematologic cancer	3.71e-05	0.000237	CcSEcCtD
Amifostine—Dizziness—Betamethasone—hematologic cancer	3.71e-05	0.000237	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—hematologic cancer	3.69e-05	0.000236	CcSEcCtD
Amifostine—Nausea—Triamcinolone—hematologic cancer	3.67e-05	0.000235	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—hematologic cancer	3.64e-05	0.000233	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—hematologic cancer	3.64e-05	0.000232	CcSEcCtD
Amifostine—Somnolence—Methotrexate—hematologic cancer	3.63e-05	0.000232	CcSEcCtD
Amifostine—Hypersensitivity—Prednisone—hematologic cancer	3.6e-05	0.00023	CcSEcCtD
Amifostine—Hypotension—Epirubicin—hematologic cancer	3.57e-05	0.000228	CcSEcCtD
Amifostine—Vomiting—Dexamethasone—hematologic cancer	3.56e-05	0.000228	CcSEcCtD
Amifostine—Vomiting—Betamethasone—hematologic cancer	3.56e-05	0.000228	CcSEcCtD
Amifostine—ENPP1—Disease—MAP2K1—hematologic cancer	3.55e-05	0.000424	CbGpPWpGaD
Amifostine—Rash—Dexamethasone—hematologic cancer	3.53e-05	0.000226	CcSEcCtD
Amifostine—Rash—Betamethasone—hematologic cancer	3.53e-05	0.000226	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.53e-05	0.000226	CcSEcCtD
Amifostine—Dermatitis—Betamethasone—hematologic cancer	3.53e-05	0.000226	CcSEcCtD
Amifostine—Dermatitis—Dexamethasone—hematologic cancer	3.53e-05	0.000226	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3CD—hematologic cancer	3.53e-05	0.000421	CbGpPWpGaD
Amifostine—Shock—Doxorubicin—hematologic cancer	3.48e-05	0.000222	CcSEcCtD
Amifostine—Pruritus—Prednisone—hematologic cancer	3.45e-05	0.000221	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—hematologic cancer	3.45e-05	0.00022	CcSEcCtD
Amifostine—Dyspnoea—Epirubicin—hematologic cancer	3.4e-05	0.000218	CcSEcCtD
Amifostine—Somnolence—Epirubicin—hematologic cancer	3.39e-05	0.000217	CcSEcCtD
Amifostine—ENPP1—Disease—FGF2—hematologic cancer	3.38e-05	0.000403	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CG—hematologic cancer	3.36e-05	0.000401	CbGpPWpGaD
Amifostine—Feeling abnormal—Methotrexate—hematologic cancer	3.36e-05	0.000215	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3R1—hematologic cancer	3.33e-05	0.000397	CbGpPWpGaD
Amifostine—Nausea—Dexamethasone—hematologic cancer	3.33e-05	0.000213	CcSEcCtD
Amifostine—Nausea—Betamethasone—hematologic cancer	3.33e-05	0.000213	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—hematologic cancer	3.3e-05	0.000211	CcSEcCtD
Amifostine—Urticaria—Methotrexate—hematologic cancer	3.24e-05	0.000207	CcSEcCtD
Amifostine—ENPP1—Disease—JAK2—hematologic cancer	3.24e-05	0.000386	CbGpPWpGaD
Amifostine—Dizziness—Prednisone—hematologic cancer	3.23e-05	0.000206	CcSEcCtD
Amifostine—Body temperature increased—Methotrexate—hematologic cancer	3.23e-05	0.000206	CcSEcCtD
Amifostine—ENPP1—Disease—MDM2—hematologic cancer	3.16e-05	0.000377	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—hematologic cancer	3.15e-05	0.000201	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—hematologic cancer	3.15e-05	0.000201	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—hematologic cancer	3.14e-05	0.000201	CcSEcCtD
Amifostine—ENPP1—Metabolism—CREBBP—hematologic cancer	3.12e-05	0.000372	CbGpPWpGaD
Amifostine—Vomiting—Prednisone—hematologic cancer	3.1e-05	0.000198	CcSEcCtD
Amifostine—Rash—Prednisone—hematologic cancer	3.08e-05	0.000197	CcSEcCtD
Amifostine—ENPP1—Disease—MTOR—hematologic cancer	3.08e-05	0.000367	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CB—hematologic cancer	3.08e-05	0.000367	CbGpPWpGaD
Amifostine—Dermatitis—Prednisone—hematologic cancer	3.08e-05	0.000197	CcSEcCtD
Amifostine—ENPP1—Disease—CD4—hematologic cancer	3.07e-05	0.000366	CbGpPWpGaD
Amifostine—Urticaria—Epirubicin—hematologic cancer	3.03e-05	0.000194	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—hematologic cancer	3.02e-05	0.000193	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—hematologic cancer	3.01e-05	0.000192	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CD—hematologic cancer	2.96e-05	0.000352	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALB—hematologic cancer	2.92e-05	0.000348	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—hematologic cancer	2.91e-05	0.000186	CcSEcCtD
Amifostine—Nausea—Prednisone—hematologic cancer	2.9e-05	0.000185	CcSEcCtD
Amifostine—ENPP1—Disease—CDKN1B—hematologic cancer	2.89e-05	0.000344	CbGpPWpGaD
Amifostine—Pruritus—Methotrexate—hematologic cancer	2.89e-05	0.000184	CcSEcCtD
Amifostine—Hypersensitivity—Epirubicin—hematologic cancer	2.81e-05	0.00018	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—hematologic cancer	2.81e-05	0.000179	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—hematologic cancer	2.79e-05	0.000179	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3R1—hematologic cancer	2.79e-05	0.000333	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—hematologic cancer	2.7e-05	0.000173	CcSEcCtD
Amifostine—Dizziness—Methotrexate—hematologic cancer	2.7e-05	0.000172	CcSEcCtD
Amifostine—ENPP1—Disease—CDKN1A—hematologic cancer	2.67e-05	0.000318	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—hematologic cancer	2.66e-05	0.000317	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—hematologic cancer	2.6e-05	0.000166	CcSEcCtD
Amifostine—Vomiting—Methotrexate—hematologic cancer	2.59e-05	0.000166	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CB—hematologic cancer	2.58e-05	0.000307	CbGpPWpGaD
Amifostine—Rash—Methotrexate—hematologic cancer	2.57e-05	0.000164	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—hematologic cancer	2.57e-05	0.000164	CcSEcCtD
Amifostine—ENPP1—Disease—EP300—hematologic cancer	2.54e-05	0.000302	CbGpPWpGaD
Amifostine—Dizziness—Epirubicin—hematologic cancer	2.52e-05	0.000161	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—hematologic cancer	2.5e-05	0.00016	CcSEcCtD
Amifostine—ENPP1—Disease—SRC—hematologic cancer	2.47e-05	0.000294	CbGpPWpGaD
Amifostine—Vomiting—Epirubicin—hematologic cancer	2.43e-05	0.000155	CcSEcCtD
Amifostine—Nausea—Methotrexate—hematologic cancer	2.42e-05	0.000155	CcSEcCtD
Amifostine—Rash—Epirubicin—hematologic cancer	2.41e-05	0.000154	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—hematologic cancer	2.41e-05	0.000154	CcSEcCtD
Amifostine—ENPP1—Disease—STAT3—hematologic cancer	2.38e-05	0.000283	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRAS—hematologic cancer	2.37e-05	0.000283	CbGpPWpGaD
Amifostine—Dizziness—Doxorubicin—hematologic cancer	2.34e-05	0.000149	CcSEcCtD
Amifostine—ENPP1—Disease—MAPK3—hematologic cancer	2.27e-05	0.000271	CbGpPWpGaD
Amifostine—Nausea—Epirubicin—hematologic cancer	2.27e-05	0.000145	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—hematologic cancer	2.25e-05	0.000144	CcSEcCtD
Amifostine—Rash—Doxorubicin—hematologic cancer	2.23e-05	0.000142	CcSEcCtD
Amifostine—ENPP1—Metabolism—PTEN—hematologic cancer	2.23e-05	0.000265	CbGpPWpGaD
Amifostine—Dermatitis—Doxorubicin—hematologic cancer	2.23e-05	0.000142	CcSEcCtD
Amifostine—ENPP1—Disease—MYC—hematologic cancer	2.21e-05	0.000263	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—hematologic cancer	2.2e-05	0.000263	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—EP300—hematologic cancer	2.12e-05	0.000253	CbGpPWpGaD
Amifostine—Nausea—Doxorubicin—hematologic cancer	2.1e-05	0.000134	CcSEcCtD
Amifostine—ENPP1—Disease—KRAS—hematologic cancer	2.04e-05	0.000243	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—hematologic cancer	1.88e-05	0.000224	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—hematologic cancer	1.74e-05	0.000207	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—hematologic cancer	1.66e-05	0.000198	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—hematologic cancer	1.57e-05	0.000187	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—hematologic cancer	1.53e-05	0.000183	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—hematologic cancer	1.28e-05	0.000153	CbGpPWpGaD
